Adjustment of Open-Loop Settings to Improve Closed-Loop Results in Type 1 Diabetes: A Multicenter Randomized Trial

被引:54
作者
Dassau, Eyal [1 ,2 ]
Brown, Sue A. [3 ]
Basu, Ananda [4 ]
Pinsker, Jordan E. [2 ]
Kudva, Yogish C. [4 ]
Gondhalekar, Ravi [1 ,2 ]
Patek, Steve [3 ]
Lv, Dayu [3 ]
Schiavon, Michele [5 ]
Lee, Joon Bok [1 ,2 ]
Man, Chiara Dalla
Hinshaw, Ling [4 ]
Castorino, Kristin [2 ]
Mallad, Ashwini [4 ]
Dadlani, Vikash [4 ]
McCrady-Spitzer, Shelly K. [4 ]
McElwee-Malloy, Molly [3 ]
Wakeman, Christian A. [3 ]
Bevier, Wendy C. [2 ]
Bradley, Paige K. [2 ]
Kovatchev, Boris [3 ]
Cobelli, Claudio [5 ]
Zisser, Howard C. [1 ,2 ]
Doyle, Francis J., III [1 ,2 ]
机构
[1] Univ Calif Santa Barbara, Dept Chem Engn, Santa Barbara, CA 93106 USA
[2] William Sansum Diabet Ctr, Santa Barbara, CA 93105 USA
[3] Univ Virginia, Ctr Diabet Technol, Charlottesville, VA 22904 USA
[4] Mayo Clin, Endocrine Res Unit, Rochester, MN 55905 USA
[5] Univ Padua, Dept Informat Engn, I-35131 Padua, Italy
基金
美国国家卫生研究院;
关键词
ARTIFICIAL PANCREAS; INSULIN DELIVERY; CLINICAL-EVALUATION; PREDICTIVE CONTROL; GLYCEMIC CONTROL; BIONIC PANCREAS; CROSSOVER TRIAL; GLUCOSE CONTROL; FUZZY-LOGIC; ADULTS;
D O I
10.1210/jc.2015-2081
中图分类号
R5 [内科学];
学科分类号
100201 [内科学];
摘要
Context: Closed-loop control (CLC) relies on an individual's open-loop insulin pump settings to initialize the system. Optimizing open-loop settings before using CLC usually requires significant time and effort. Objective: The objective was to investigate the effects of a one-time algorithmic adjustment of basal rate and insulin to carbohydrate ratio open-loop settings on the performance of CLC. Design: This study reports a multicenter, outpatient, randomized, crossover clinical trial. Patients: Thirty-seven adults with type 1 diabetes were enrolled at three clinical sites. Interventions: Each subject's insulin pump settings were subject to a one-time algorithmic adjustment based on 1 week of open-loop (i.e., home care) data collection. Subjects then underwent two 27-hour periods of CLC in random order with either unchanged (control) or algorithmic adjusted basal rate and carbohydrate ratio settings (adjusted) used to initialize the zone-model predictive control artificial pancreas controller. Subject's followed their usual meal-plan and had an unannounced exercise session. Main Outcomes and Measures: Time in the glucose range was 80-140 mg/dL, compared between both arms. Results: Thirty-two subjects completed the protocol. Median time in CLC was 25.3 hours. The median time in the 80-140 mg/dl range was similar in both groups (39.7% control, 44.2% adjusted). Subjects in both arms of CLC showed minimal time spent less than 70 mg/dl (median 1.34% and 1.37%, respectively). There were no significant differences more than 140 mg/dL. Conclusions: A one-time algorithmic adjustment of open-loop settings did not alter glucose control in a relatively short duration outpatient closed-loop study. The CLC system proved very robust and adaptable, with minimal (<2%) time spent in the hypoglycemic range in either arm.
引用
收藏
页码:3878 / 3886
页数:9
相关论文
共 27 条
[1]
Inpatient Trial of an Artificial Pancreas Based on Multiple Model Probabilistic Predictive Control with Repeated Large Unannounced Meals [J].
Cameron, Fraser ;
Niemeyer, Guenter ;
Wilson, Darrell M. ;
Bequette, B. Wayne ;
Benassi, Kari S. ;
Clinton, Paula ;
Buckingham, Bruce A. .
DIABETES TECHNOLOGY & THERAPEUTICS, 2014, 16 (11) :728-734
[2]
Clinical Evaluation of a Personalized Artificial Pancreas [J].
Dassau, Eyal ;
Zisser, Howard ;
Harvey, Rebecca A. ;
Percival, Matthew W. ;
Grosman, Benyamin ;
Bevier, Wendy ;
Atlas, Eran ;
Miller, Shahar ;
Nimri, Revital ;
Jovanovic, Lois ;
Doyle, Francis J., III .
DIABETES CARE, 2013, 36 (04) :801-809
[3]
Dassau Eyal, 2008, J Diabetes Sci Technol, V2, P863
[4]
Autonomous and Continuous Adaptation of a Bihormonal Bionic Pancreas in Adults and Adolescents With Type 1 Diabetes [J].
El-Khatib, Firas H. ;
Russell, Steven J. ;
Magyar, Kendra L. ;
Sinha, Manasi ;
McKeon, Katherine ;
Nathan, David M. ;
Damiano, Edward R. .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2014, 99 (05) :1701-1711
[5]
Gondhalekar R, AM CONTR C 2014 PORT
[6]
Gondhalekar Ravi, 2013, J Diabetes Sci Technol, V7, P1446
[7]
Grosman Benyamin, 2010, J Diabetes Sci Technol, V4, P961
[8]
Comparison of dual-hormone artificial pancreas, single-hormone artificial pancreas, and conventional insulin pump therapy for glycaemic control in patients with type 1 diabetes: an open-label randomised controlled crossover trial [J].
Haidar, Ahmad ;
Legault, Laurent ;
Messier, Virginie ;
Mitre, Tina Maria ;
Leroux, Catherine ;
Rabasa-Lhoret, Remi .
LANCET DIABETES & ENDOCRINOLOGY, 2015, 3 (01) :17-26
[9]
Clinical Evaluation of an Automated Artificial Pancreas Using Zone-Model Predictive Control and Health Monitoring System [J].
Harvey, Rebecca A. ;
Dassau, Eyal ;
Bevier, Wendy C. ;
Seborg, Dale E. ;
Jovanovic, Lois ;
Doyle, Francis J., III ;
Zisser, Howard C. .
DIABETES TECHNOLOGY & THERAPEUTICS, 2014, 16 (06) :348-357
[10]
Harvey Rebecca A, 2012, J Diabetes Sci Technol, V6, P1345